Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...

Removing EPO signalling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...

AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...